Overview

Also known as:

Mandibuloacral dysplasia progeroid syndrome MADaM MDPS

FDA & Trial Timeline

1 event

Mar 2026Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants

University Hospital, Basel, Switzerland — PHASE1

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Mandibuloacral dysplasia associated to MTX2.

View clinical trials →

Clinical Trials

View all trials with filters →

No actively recruiting trials found for Mandibuloacral dysplasia associated to MTX2 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mandibuloacral dysplasia associated to MTX2 community →

Specialists

View all specialists →

No specialists are currently listed for Mandibuloacral dysplasia associated to MTX2.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers

🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mandibuloacral dysplasia associated to MTX2.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mandibuloacral dysplasia associated to MTX2Forum →

No community posts yet. Be the first to share your experience with Mandibuloacral dysplasia associated to MTX2.

Start the conversation →

Latest news about Mandibuloacral dysplasia associated to MTX2

Disease timeline:

New recruiting trial: Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants

A new clinical trial is recruiting patients for Mandibuloacral dysplasia associated to MTX2

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.